Nancy Vander-Velde
Medical Oncology New Orleans, LA Medical Doctor
NPI 1235172511 CMS profile 853536
1601 Perdido St, Attn: Medicine Office, New Orleans, LA 70112
General payments
$1,536
Research payments
$10,318
Ownership & investment interest
$0
Through program year 2025, Nancy Vander-Velde of New Orleans, LA is reported in the CMS Open Payments database as having received $1,536 across 19 general payments and $10,318 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 64th percentile of Medical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $184 | 6 | |
| 2024 | General | $195 | 8 | |
| 2022 | General | $44 | 1 | |
| 2020 | General | $15 | 1 | |
| 2020 | Research | $10,318 | 2 | |
| 2019 | General | $1,099 | 3 |
Beside peers
- Nancy Vander-Velde
- Medical Oncology median
- Middle half of Medical Oncology
- National median
In program year 2025, general payments to Nancy Vander-Velde were reported at $184. Among 3,316 Medical Oncology profiles paid that year, the median was $1,128 and the middle half received between $147 and $5,675.
Show as a table
| Year | Nancy Vander-Velde | Medical Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,099 | $968 | $140–$6,658 | $163 |
| 2020 | $15 | $747 | $102–$5,891 | $114 |
| 2021 | $0 | $430 | $50–$4,098 | $132 |
| 2022 | $44 | $812 | $127–$4,907 | $149 |
| 2023 | $0 | $957 | $144–$5,248 | $160 |
| 2024 | $195 | $1,042 | $149–$5,650 | $164 |
| 2025 | $184 | $1,128 | $147–$5,675 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
21 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Medical Oncology in Louisiana
Practitioners in the same specialty and state, ranked by reported value.
All Medical Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Louisiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.